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Abstract: 
Human populations are routinely exposed to per- and polyfluorinated compounds 
(PFAS), a class of fluorinated compounds characterized by strong carbon-fluorine bonds. 
Common routes of exposure to PFAS include via drinking water, non-stick pans, carpets and 
other surfaces treated with PFAS to obtain water repellent properties. PFAS, including 
perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA), are linked to adverse 
developmental outcomes such as preeclampsia and low infant birth weight. These health 
outcomes may be mediated by the placenta, an essential developmental organ. Recently, a newly 
developed PFAS, hexafluoropropylene oxide dimer acid (HFPO-DA), known by the trade name 
GenX, has been found in high concentrations in municipality drinking water in Wilmington, NC. 
In light of ongoing human exposure, it is important to determine the effect of PFOS, PFOA and 
GenX on the placenta. Placental DNA methylation has been linked to adverse neurocognitive 
outcomes and thus may serve as an indicator of future development. Experiments were first 
conducted to determine if binding interactions in cell culture serum media could sequester PFAS. 
JEG3 placental trophoblasts were treated with PFOS, PFOA and GenX in serum (S+) and serum 
free (S-) media. PFOS alone was found to induce cytotoxicity at a lower dose in S- media than in 
S+ media. Subsequently, to assess the impact of PFAS on the placental epigenome, DNA 
methylation levels were measured in response to PFOS, PFOA and GenX exposure in S+ and S- 
media. LINE-1 DNA methylation was used as a proxy for global methylation. No significant 
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differences from the control were observed (p < 0.05). The results provide evidence that PFOS, 
PFOA and GenX do not alter LINE-1 DNA methylation in JEG3 trophoblasts. Further research 
is needed to elucidate the specific impact of PFOS, PFOA and GenX on global and local DNA 
methylation patterns in the placenta.  
 
1. Introduction  
Per- and polyfluoroalkyl substances (PFAS), compounds characterized by a fluorinated 
carbon chain(s), are produced for numerous consumer and industrial products such as lubricants, 
paints, and cosmetics (1). Following production, PFAS are released into the environment through 
point and non-point sources including the disposal of industrial waste, the use of products 
containing PFAS, and the degradation and disposal of these products (2, 3). Due to the strong 
chemical bonds that characterize PFAS, these compounds are highly resistant to degradation and, 
once in the environment, persist for decades (1, 4).  
Human exposure to PFAS can occur through a variety of mechanisms. Common routes of 
exposure include drinking water contaminated with PFAS and contact with products containing 
PFAS, such as waterproof materials, anti-stick surfaces on cookware, carpets treated to repel 
stains, and more (2, 5, 6). Drinking water is one of the most significant sources of human 
exposure to PFAS (6). One mechanism by which PFAS have traditionally entered the water 
supply is through the use of aqueous film forming foams (AFFF’s), which have been employed 
extensively at military and civilian sites including airports and oil refineries (3, 7). Drinking 
water has also been contaminated with PFAS via the release of industrial byproducts into water 
sources upstream of wastewater treatment plants (2). Because PFAS are not removed by 
traditional waste water filtration techniques, these compounds enter municipality drinking water 
sourced from contaminated water supplies (4). As a result of widespread use and contamination, 
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two of the most well-known PFAS, perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic 
acid (PFOA), have been detected in 100% of tested populations within the United States (8).  
Of importance, studies have observed links between PFOS and PFOA exposure and 
adverse pregnancy outcomes, including preeclampsia and low birth weight (9-11). PFAS have 
also been shown to cross the placental barrier, indicating a method of fetal exposure (12). In 
addition, in vivo studies in murine models demonstrated that high concentrations of PFOS and 
PFOA induce developmental toxicity, including fetal growth retardation, decreases in placental 
efficiency, and increases in the number of dead fetuses (12-14).  
Following the publication of early studies exposing the developmental risk of PFAS 
exposure, public backlash and the prospect of government legislation induced corporations to 
phase out legacy compounds such as PFOS and PFOA and to develop replacement compounds 
(4). Industry shifted production to shorter chain compounds that were predicted to be less 
bioaccumulative than their predecessors, despite the fact that limited testing has been completed 
to determine the developmental toxicity of these compounds (15-20).  
Recently, a newly utilized replacement PFAS, hexafluoropropylene oxide dimer acid 
(HFPO-DA), known by the trade name GenX, was discovered in large quantities in the drinking 
water of residents of Wilmington, NC in the Cape Fear River watershed (2). At the time this 
research was initiated, very little research had been conducted to determine the impact of GenX 
on developmental toxicity. Since human populations in the Cape Fear region, including 
expectant mothers, have been exposed to abnormally high concentrations of GenX via drinking 
water, it is of paramount importance to determine the developmental impact of replacement 
PFAS such as GenX (2).   
 
  4 
The placenta is an essential organ in fetal development with numerous functions in 
pregnancy, including gas exchange, nutrient delivery and waste removal, and endocrine function 
(21-23). PFAS exposure during pregnancy has been shown to impact the placenta by altering 
lipid content and aromatase function. Additionally, exposure to certain PFAS is associated with 
adverse pregnancy outcomes as mentioned previously (9, 10, 17). It is possible that PFAS-
associated pregnancy outcomes such as these could be mediated by the placenta (23). Unique to 
the placenta and essential to its function, placental trophoblastic cells are essential mediators of 
maternal-fetal interactions (24). As an in vitro model for placental trophoblasts, the JEG3 cell 
line was selected for experimentation.  
Current in vitro toxicology research relies on cell culture to investigate the effects of 
chemical exposure. Cell culture traditionally involves exposing cells to chemicals in serum 
media (S+). However, research indicates that PFOS binds to serum albumin in a 1:1 molar ratio 
(25). Therefore, it is possible that albumin present in cell culture media sequesters PFOS, thus 
causing cells to be exposed to a lower concentration of PFOS then anticipated. If albumin is able 
to sequester other PFAS such as PFOA and GenX in a similar manner, this could reduce the 
accuracy of in vitro testing and subsequent regulations. A recent experiment found that cells 
treated with PFOS in S+ media accumulated 98% less PFOS than cells treated in serum free 
media (S-), which supports the hypothesis that cells treated in S+ media are internalizing a lower 
concentration of PFOS (16).  
Cytotoxicity analysis provides a simple method to further investigate the effect of media 
on PFOS, PFOA and GenX treatment in vitro.  Additionally, at the time this research was 
initiated, no work had been done to analyze GenX cytotoxicity in human placental cells (26). In 
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light of PFOS-albumin binding interactions, we hypothesized that PFOS, PFOA and GenX will 
induce cytotoxicity at a lower treatment dose in S- media than in S+ media. 
Following experiments to determine PFOS, PFOA and GenX cytotoxicity, our research 
shifted focus to investigate the effect of PFAS on the epigenome. The epigenome is an important 
research target because of its essential role in the regulation of the human genome from 
preimplantation embryonic development until death (27). The most thoroughly studied 
epigenetic modification to cellular DNA is methylation, which involves the addition of a methyl 
group to the C5 position of a cytosine residue proximal to a guanine residue (28). Other 
epigenetic modifications include histone acetylation, histone methylation, and RNA-associated 
silencing (29). Each of these modifications is mediated by a group of proteins, known 
collectively as epigenetic machinery proteins, that perform and reverse epigenetic modifications.  
Regarding the placenta, the dysregulation of the placental epigenome has been associated 
with adverse health outcomes in both the short and long term, including neurobehavioral and 
neurocognitive outcomes (30-32). Although PFAS have been shown to alter gene expression 
patterns in cord blood, little research has been conducted to determine how PFAS impact the 
placental epigenome (33). Data collected previously by the Fry lab indicate that JEG3 exposure 
to PFOS, PFOA and GenX induced significant changes in mRNA expression of several key 
epigenetic machinery proteins (in preparation) (Appendix A). Levels of mRNA transcripts of 
metastasis associated 1 family member 2 protein (MTA2), a methyltransferase, were 
significantly upregulated upon exposure to GenX and PFOA at a concentration of 1000 ng/mL. 
The goal of this research was therefore to investigate the impact of PFOS, PFOA and GenX on 
placental DNA methylation. Because of MTA2’s role in regulating DNA methylation, it is 
hypothesized that PFOA and GenX exposure induces measurable changes in DNA methylation 
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levels in the placenta. PFOS is hypothesized to have no effect on DNA methylation since PFOS 
exposure did not significantly alter MTA2 expression.  
To determine the impact of PFOS, PFOA, and GenX on DNA methylation, long 
interspersed nucleotide elements (LINE-1) DNA methylation was used as a surrogate for global 
DNA methylation. LINE-1 DNA methylation is considered an effective proxy for global DNA 
methylation and has the advantage of being notably more cost effective than site-specific 
methylation analysis of the entire genome (34). LINE-1 elements are repetitive sequences that 
comprise about 17% of human DNA (34, 35). Although LINE-1 repeats are not known to 
contain genes or regulatory elements, these sequences are heavily methylated (34, 36).  PFAS 
exposure has been associated with changes in LINE-1 methylation levels in peripheral blood 
leukocytes, which indicates the potential for PFAS to induce alterations in LINE-1 methylation 
(37).   
 Since previous cytotoxicity data from the Fry lab demonstrated that the type of media 
used in cell culture impacts PFOS cytotoxicity (in preparation), two types of media were used, 
serum media (S+) that contained fetal bovine serum (FBS), and serum free media (S-) that 
sustained cells without FBS (not serum starved). Additional rational for this decision includes the 
previously stated fact that PFOS has been shown to bind to albumin, a key component of FBS, in 
a 1:1 molar ratio (25), therefore potentially reducing the cellular concentrations of PFOS. 
Furthermore, PFOA and GenX induced MTA2 expression changes only in cells dosed in S- 
media and not in cells dosed S+ media (in preparation) (Appendix A). PFOS did not alter 
changes in MTA2 expression in either S+ or S- media. Therefore, it was hypothesized that PFOA 
and GenX will alter LINE-1 DNA methylation only in S- media and PFOS would have no effect 
in either media type.  
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2. Materials and methods  
2.1. Acquisition of Compounds and Cell Line  
Laboratory members acquired compounds from SynQuest Laboratories (SynQuest 
Laboratories, Alachua FL). Stock solutions were prepared in methanol and stored at -20°C. The 
JEG3 cell line was purchased from the American Type Culture Collection (Manassas VA) and 
cultured in serum media (S+) or serum free media (S-) media as described in Appendix B. The 
S- media was a supplemental media (OptiPRO serum free media) that provides nutrients to cells 
(not serum starved) without the use of fetal bovine serum (FBS). S- media was used in addition 
to S+ media in order to determine the effect of media on cytotoxicity and LINE-1 DNA 
methylation.  
2.2. Cytotoxicity Assay   
2.2.1. Treatment: 
JEG3 human placental choriocarcinoma cell line was cultured in S+ media until 90% 
confluent according the protocol described in Meakin et al., 2019 (38). Cell viability and density 
were determined using a cell viability analyzer, model Vi-Cell XR (Beckman Coulter, Brea CA), 
and cells were seeded into 96-well plates at a density of 7,500 cells per well in S+ media. 
Following a 24 hr incubation, media was changed and replaced with either S+ media or S- 
media. Treatment conditions and media composition were according to Appendix B. Overall 
experimental design followed Figure 1. Cells were incubated for an additional 24 hrs during 
which the cells were allowed to adjust to media. After 24 hr acclimation to media, cells in S+ and 
S- media were treated with varying concentrations of PFOS, PFOA and GenX according to 
Appendices C and D. Treatment was randomized across each plate. S+ and S- treatment and 
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controls contained 0.1% methanol, as observed in stock solutions. All treatment groups and 
controls were performed using three or more biological replicates. 
Figure 1. Cytotoxicity assay experimental design 
 
Acclimation to media and treatment periods were 24 hrs each, with cytotoxicity measured 
after 24 hr treatment. This figure depicts hypothesized binding of PFAS to serum albumin and 
hypothesized results: cells treated in S- media experience toxicity at a concentration of PFAS 
that is not toxic to cells treated in S+ media. Cytotoxicity is indicated by an increased number of 
dead cells, according to the figure legend. 
2.2.2. Cell Viability 
Cell viability was determined using a resazurin-based assay. High purity resazurin salt 
was dissolved, filtered, and sterilized in preparation. 22 hrs after treatment, 20 µL of resazurin 
dye was added to each well. Cells were incubated for 2 hrs at 37°C for an additional 2 hrs. 
Viable cells convert resazurin into the fluorescent product resorufin (38). Cell viability was 
measured a total of 24 hrs after treatment. Cell viability was analyzed using a GloMax®-Multi+ 
Detection System spectrometer, model E9032 (Promega, Madison WI). Fluorescence was 
recorded at 560 nm excitation and 590 nm emission. 
2.2.3 Data Analysis 
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Statistical analysis of cell viability results was performed in Microsoft Excel for Mac 
(Version 16.16, Redmond CA www.microsoft.com/en-us). Treatment viability was standardized 
against control viability to determine percent viability. Within plates, average viability and 
standard deviation were determined. Average viability and standard deviation between plates 
were determined. Further statistical analysis was conducted via an ANCOVA and pairwise t-test 
in RStudio for Mac (Version 1.1.423, Boston, MA www.rstudio.com).   
2.3. LINE-1 DNA Methylation Assay  
2.3.1. Treatment and DNA Isolation 
JEG3 cell line was cultured in S+ media and cell viability and density were determined as 
described in section 2.2.1. Treatment. Cells were seeded in a six-well plate at a concentration of 
0.5 x 106 cells per well in S+ and allowed to incubate 24 hrs. Following a 24 hr incubation, 
media was changed and replaced with either S+ media or S- media. Treatment conditions and 
media composition were according to Appendix B. Overall experimental design followed 
Figure 2. Cells were incubated for an additional 24 hrs during which the cells were allowed to 
adjust to media. After 24 hr acclimation to media, cells in S+ and S- media were treated with 
PFOS, PFOA and GenX at 100 and 1000 ng/mL for 24 hrs according to Appendix C. These 
concentrations were chosen in an effort to approximate chronic PFAS exposure during an acute 
exposure period (24 hrs). 100 ng/mL is a relatively high environmentally relevant exposure. 
1000 ng/mL is not an environmentally relevant exposure, but was selected to account for a 
shorter exposure time in vitro (24 hrs) compared to chronic exposure in vivo. Media for controls 
and treatment groups was adjusted to have a concentration of 0.1% methanol to control for 
methanol exposure.  
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Following 24 hr treatment, cells were harvested for DNA isolation. Control and treatment 
cells were harvested in 350 µL of buffer RTL (Quiagen, Cat. No. 79216). DNA isolation was 
performed using a QIAcube (Qiagen, Valencia CA) via the AllPrep DNA/RNA/miRNA 
Universal Kit (#80224) according to the manufacturer's protocol. DNA concentration was 
determined using a NanoDrop 1000 spectrometer (ThermoFisher Scientific, Waltham MA). All 
treatment groups and controls were performed using three or more biological replicates.  
Figure 2. LINE-1 DNA methylation assay experimental design 
 
The acclimate to media and treatment periods were 24 hrs each, with cells harvested for 
DNA methylation analysis after 24 hr treatment. This figure depicts hypothesized binding of 
PFAS to serum albumin, which sequesters PFAS from the cells. 
2.3.2. Global DNA methylation determination via LINE-1 methylation ELISA  
After treatment and harvesting, an enzyme-linked immunofluorescence assay (ELISA) 
was utilized to determine genome-wide LINE-1 methylation. The Global DNA Methylation 
LINE-1 Kit (Active Motif, Carlsbad CA) was applied according to the manufacturer’s protocol, 
with the following alterations: (1) DNA was diluted to a concentration of 50 ng which 
preliminary experiments found to be optimal, and (2) technical replicates of the standard curve 
and blank were performed in triplicate, and technical replicates for the samples were performed 
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in duplicate, with the exception of one sample that was performed in triplicate. Each of the three 
biological controls were composed of three samples. Two technical replicates of each sample 
were performed, as described above. Quantification of LINE-1 methylation was performed using 
a SpectraMax® ID5 spectrometer (Molecular Devices, San Jose CA) and associated software 
(SoftMax Pro, Version 7.1).  
2.3.3. Data Analysis and Statistical Analysis 
 Analysis was performed using Microsoft Excel (Version 16.16.16, Redmond WA, 
www.microsoft.com/en-us) and GraphPad Prism (Version 8.3.0, La Jolla CA, 
www.graphpad.com). In Excel, the reference wavelength (655 nm) was subtracted from the test 
absorbance wavelength (450 nm) for each cell. The plate technical replicates of the standard 
curve, samples and blank were averaged, then the average blank value was subtracted from both 
the average standard curve values and the average sample values to produce net values. 
GraphPad was used to plot the standard curve and determine a line of best fit. Net values were 
interpolated using a line of best fit (S+ R2 =0.9745; S- R2 =0.9949) to produce interpolated 
values. In Excel, the interpolated values were adjusted to account for the 2x dilution of samples 
to 50 ng. Interpolated values of the plate technical replicates of the control were averaged to 
produce biological replicates, which were then averaged themselves to produce the control 
average value. Interpolated values were standardized to the control average value to produce 
standardized values. Biological replicates were then averaged, and the standard deviation was 
determined.  
In GraphPad, an analysis of variance (ANOVA) was used to test for an overall difference 
between the control and treatment groups by media. Post-hoc Dunnett’s multiple comparisons 
test with a single pooled variance was conducted to test for differences between the control and 
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each treatment group. A second ANOVA was used to test for an overall difference between 
treatment groups. Treatment groups were able to be compared between media type (S+ and S-) 
because each treatment group had been previously standardized to its respective control in S+ or 
S- media. Post-hoc Tukey’s multiple comparisons test was conducted to test for differences 
between individual treatment groups compared to every other treatment group. Significance for 
all analysis was set at p < 0.05.  
 
3. Results 
3.1. Cytotoxicity Analysis 
Given the known potential for PFOS to bind to albumin, we sought to understand the 
cytotoxicity of PFOS, PFOA and GenX over a range of concentrations in serum (S+) and serum 
free (S-) media (25). Cells were treated in two media types to investigate whether the presence of 
albumin in the S+ media affected cytotoxicity. This experiment was also performed to establish 
the cytotoxicity of GenX on JEG3 trophoblasts.  
Cells were exposed to a range of concentrations of each compound for 24 hrs and cell 
viability was measured using a resazurin assay. Cytotoxicity was determined to be the 
concentration of PFAS that reduced cell viability by 50% or more, known as the lethal 
concentration (LC50). PFOS exposure of 50,000 and 100,000 ng/mL was found to significantly 
decrease cell viability in S- media. The LC50 of PFOS in S- media was observed to be 50,000 
ng/mL. No other concentration of PFOS, PFOA or GenX significantly decreased cell viability in 
S+ or S- media. PFOS and PFOA were found to significantly increase cell viability in S+ media 
at 50,000 ng/mL (PFOA) and 100,000 ng/mL (PFOS and PFOA) (Figure 3).  
The results suggest that PFOS is more cytotoxic in S- media than in S+ media. The 
results also suggest that PFOS is more cytotoxic than PFOA and GenX in S- media. Because 
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PFOA and GenX were not cytotoxic at any concentrations tested, the effect of media on the 
cytotoxicity of these compounds could not be determined. The concentration at which GenX is 
cytotoxic (LC50) to JEG3 trophoblasts could not be determined for the same reason. 
Additionally, it was unexpected to observe an increase in cell viability in cells exposed to the 
highest concentrations of PFOS and PFOA.  
Figure 3. Effect of PFOS, PFOA and GenX on cell viability in S+ and S- media. 
 
Cell viability after 24 hr treatment with PFOS (n=3), PFOA (n=3) and GenX (n=4) at the 
following concentrations: 0.5, 1, 100, 500, 1,000, 2,000, 5,000, 10,000, 50,000, and 100,000 
ng/mL. Cell viability values are standardized to respective controls. * indicates a significant 
difference in cell viability from the control by analysis of covariance (ANCOVA) and post-hoc 
analysis (p < 0.05). Error bars are standard deviation. Lethal concentration of PFOS (LC50) was 
observed in S- media at concentrations of 50,000 ng/mL (50.0% viability) and 100,000 ng/mL 
(16.7% viability). LC50 of PFOS was not observed in S+ media. LC50 of PFOA and GenX was 
not observed in either S- or S+ media. Significant increases in cell viability were observed in 
PFOS (100,000 ng/mL) and PFOA (50,000 and 100,000 ng/mL) in S+ media. 
3.2. LINE-1 DNA Methylation Assay 
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 Since GenX altered MTA2 methyltransferase expression (in preparation) and variations 
in placental DNA methylation are correlated with poor neurological outcomes, we desired to 
determine the impact of PFOS, PFOA and GenX on LINE-1 methylation levels in S+ and S- 
media (30, 32). LINE-1 DNA methylation served as a proxy for global DNA methylation. 
Treatment concentrations approximated environmentally relevant exposures. Two media types 
(S+ and S-) were employed to determine if the presence of albumin in S+ media affected DNA 
methylation as media had previously affected PFOS cytotoxicity. 
Cells were exposed to 100 and 1000 ng/mL of PFOS, PFOA and GenX for 24 hrs. LINE-
1 DNA methylation was measured with an enzyme-linked immunofluorescence assay (ELISA). 
Many biological replicates had a high degree of variation, as demonstrated by large standard 
deviations (Figure 4) and confidence intervals (Appendix F). PFOS, PFOA and GenX exposure 
at 100 and 1000 ng/mL did not induce significant changes in LINE-1 DNA methylation from the 
respective control in either S+ or S- media (Figure 4, Table 1). A post-hoc Dunnett’s test was 
performed to determine the p value of the comparison between the control and each treatment 
group (Table 1).  
A second analysis of variance (ANOVA) was performed to further investigate the effect 
of media on LINE-1 DNA methylation levels. This ANOVA provided a direct comparison 
between corresponding treatment groups in S+ and S- media. The ANOVA and subsequent post-
hoc Tukey’s test found a significant difference in LINE-1 DNA methylation between cells 
treated with GenX at 1000 ng/mL in S+ and S- media. No other significant differences were 
observed (Appendix E). 
The results indicate that PFOS, PFOA and GenX do not alter LINE-1 DNA methylation 
levels at either treatment, regardless of media. While the second ANOVA and post-hoc Tukey’s 
 
  15 
test is not conclusive since it was not originally part of the experimental design, it does suggest 
that media potentially mediates the effect of GenX exposure on LINE-1 DNA methylation.  




Data is displayed as means ± the standard deviation (SD). Treatment concentration is in 
ng/mL. Solid horizonal black lines indicate the average value of the control, dashed lines indicate 
the standard deviation of the control for S+ media and S- media, respectively. Compounds tested 
were PFOS, PFOA and GenX at 100 and 1000 ng/mL concentrations. Methylation values are 
standardized to respective controls. No significant changes in LINE-1 DNA methylation from 
the control were observed in ANOVA analysis (p < 0.05). A post-hoc Dunnett’s multiple 
comparisons test was performed to determine p values of treatment groups compared to the 
control (Table 1). A second ANOVA analysis was performed to compare corresponding 
treatment groups in S+ and S- media (p < 0.05). Treatment groups were able to be compared 
between media type (S+ and   S-) because each treatment group had been previously 
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standardized to its respective control in S+ or S- media. A post-hoc Tukey’s multiple 
comparisons test found a statistically significant difference between S+ and S- GenX 1000 
ng/mL treatment groups (p = 0.0451). * indicates a significant difference between treatment 
groups directly compared to each other, not to the control. No other significant differences were 
found between treatment groups (Appendix E).  
Table 1. Post-hoc comparison of treatment group to control in serum media (S+) and serum free 
media (S-).  






100 0.8090 0.9998 
1000 0.7355 0.8083 
PFOA 
100 0.9996 0.9997 
1000 0.9982 0.4860 
GenX 
100 0.4478 0.9283 
1000 0.2288 0.3748 
 
Post-hoc Dunnett’s multiple comparisons test between treatment groups and controls by 




Regarding the cytotoxicity analysis, we found that PFOS is cytotoxic at a lower 
concentration in S- media than in S+ media (Figure 3). PFOS was cytotoxic (LC50) in S- media 
at concentrations of 50,000 ng/mL and 100,00 ng/mL. In contrast, the same concentration of 
PFOS in S+ media did not induce cytotoxicity. This supports the hypothesis that albumin in S+ 
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media sequesters PFOS, causing cells treated in S- media to be exposed to a higher concentration 
of PFOS due to absence of PFOS-albumin binding (16).  
Cells exposed to PFOA did not experience cytotoxicity at any treatment concentration in 
either S+ or S- media. This provides evidence that PFOA is less cytotoxic than PFOS in JEG3 
cells. Previous work evaluating PFOS and PFOA cytotoxicity determined PFOS to be cytotoxic 
at a lower concentration than PFOA in JEG3 trophoblasts, which supports this finding (17, 39). 
GenX was not found to be cytotoxic in either S+ or S- media at these concentrations. These 
results indicate that GenX is also less cytotoxic than PFOS in S- media. Since no significant 
decrease in cytotoxicity was observed in S+ or S- media in cells treated with PFOA and GenX, 
no conclusions can be made regarding the effect of media on the cytotoxicity of these PFAS. As 
a result, the hypothesis that cell culture media reduces the cytotoxicity of these two compounds 
via albumin sequestering is not supported. Future analyses should increase the concentrations of 
PFOA and GenX to which cells are exposed in order to determine LC50 for these PFAS in S+ 
and S- media.  
Although PFOS was observed to differentially induce cytotoxicity in S+ and S- media, 
further research is needed to determine the effect of media on cytotoxicity. Specifically, research 
is needed to compare the internal dose of PFOS, PFOA and GenX in cells treated in S+ and in S- 
media, since serum binding has the potential to mask cytotoxic effects at lower concentrations. 
At the time this research was initiated, cytotoxicity testing for PFOS, PFOA and GenX has been 
performed in S+ with no determination of internal dose (18, 40). Based on this experiment, 
PFOS in particular is likely cytotoxic at a lower concentration in vitro than previously observed.  
Furthermore, determining the internal dose of PFAS in vitro will enable comparisons 
between the internal dose of PFOS, PFOA and GenX in human placental cells in vivo and in cell 
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culture in vitro. Cell culture treatment concentrations could then be adjusted to mimic the 
internal dose in vivo. This would enable the effects of PFOS, PFOA and GenX exposure to be 
evaluated in vitro at concentrations corresponding to those of human tissue and reduce the need 
to investigate the effects of media on cellular exposure to PFAS. 
Several of the higher concentrations of PFOS and PFOA caused a statistically significant 
increase in cell growth compared in S+ media (Figure 3). Specifically, cells treated with 100,000 
ng/mL of PFOS and 50,000 and 100,000 ng/mL of PFOA exhibited increased cell viability 
according to the assay. The same increase was not observed in cells treated in S- media. These 
results were potentially due to the mitochondrial-based nature of the resazurin assay. PFOS and 
PFOA have been shown to impact mitochondrial function by increasing oxidative capacity and 
thus might increase the rate at which resazurin is converted into the fluorescent product resorufin 
(38, 41). However, since this research was designed to investigate cytotoxicity, further research 
is needed to elucidate the importance of these results.   
4.2. LINE-1 DNA Methylation 
Due to the link between placenta DNA methylation and adverse neurological outcomes, 
the DNA methylation assay was designed to measure the effect of PFOS, PFOA and GenX on 
LINE-1 DNA methylation in a placental cell line (30, 32). The results found that exposure to 
PFOS, PFOA and GenX did not significantly alter LINE-1 methylation compared to respective 
controls at the investigated concentrations (100 or 1000 ng/ml) in either S+ or S- media (Figure 
4).  This does not support the hypothesis that PFOA and GenX would induce LINE-1 
methylation changes in S- media because these PFAS were previously found to alter MTA2 
expression (in preparation) (Appendix A). The results do support the hypothesis that PFOS will 
not induce LINE-1 methylation changes in either S+ or S- media, since PFOS had no impact on 
 
  19 
MTA2 expression. Additionally, PFOA and GenX were predicted to have no effect on LINE-1 
methylation in S- media, which was observed.  
The results of this experiment indicate that PFOS, PFOA and GenX exposure does not 
affect LINE-1 DNA methylation in JEG3 the cell line. This provides evidence that these PFAS at 
these concentrations do not impact global DNA methylation in this cell line. In relation to the 
placenta, these results imply that PFOS, PFOA and GenX do not alter LINE-1 DNA methylation 
in the placenta and therefore do not alter global DNA methylation in the placenta. Further 
research is needed to substantiate this implication.   
The results were unexpected because previous experiments in this lab observed that 
PFOS, PFOA and GenX induced significant changes in mRNA expression levels of epigenetic 
regulatory proteins (in preparation) (Appendix A). Specifically, PFOA and GenX exposure at 
1000 ng/mL resulted in a significant upregulation in MTA2 mRNA levels in S- media. It was 
therefore hypothesized that exposure to PFOA and GenX at this dose would alter LINE-1 DNA 
methylation levels through increased MTA2 activity.  
Although no treatment groups were significantly different from the control in either 
media type, one notable difference was observed in an analysis that compared treatment groups 
in S+ and S- media. Treatment with 1000 ng/mL of GenX resulted in a significant difference in 
LINE-1 DNA methylation between S+ media and S- media (Figure 4). Specifically, cells treated 
in S+ media were hypomethylated compared to cells treated in S- media. Since this difference 
was not originally hypothesized and was found a second analysis, it is not a substantial 
conclusion. However, this result does suggest the potential for serum to mediate the effect of 
GenX on LINE-1 DNA methylation, thus providing an interesting direction for future research.  
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While this is one of the first studies to reveal information about how PFAS affect 
placental trophoblast LINE-1 DNA methylation, it is not without its limitations. To begin, the 
LINE-1 assay is not site-specific, meaning that it does not detect the presence or absence of 
individual methyl groups at specific locations on the DNA. As such, an increase in methylation 
in one segment of LINE-1 repeats could have been offset by a corresponding decrease in another 
segment. This scenario would produce a result of no change with this assay despite the alteration 
in LINE-1 DNA methylation patterns.   
Additionally, the LINE-1 assay does not observe gene-specific alterations in DNA 
methylation. This experiment is therefore unable to determine how these concentrations of 
PFOS, PFOA and GenX impact the methylation patterns of specific genes. Since research has 
indicated that gene-specific alterations in methylation are correlated with various cancers, this is 
important to investigate further (42).  
A potential contributor to the lack of significance was the variation in LINE-1 DNA 
methylation levels between biological replicates (n=3) (Figure 4, Appendix F). This variation 
reduces the precision of measured LINE-1 DNA methylation levels. As a result, it is more 
difficult to observe if a significant difference is present between treatment groups and the 
control. It is possible that significant differences in LINE-1 DNA methylation levels remained 
undetected due to this lack of precision. Future experiments will use a greater number of 
biological replicates to improve experimental precision. 
Lastly, the increase in MTA2 mRNA expression that was observed in response to PFOA 
and GenX exposure a priori might not be directly correlated with increased protein expression 
(in preparation) (Appendix A). Due to the absence of a commercially available antibody to 
MTA2 at the time the experiment was conducted, a Western Blot analysis of MTA2 protein 
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expression was not performed. Although it is unlikely that mRNA expression and protein 
expression are not correlated, this remains a possibility. Collectively, the aforementioned 
limitations reduce the applicability of the results to JEG3 and placental LINE-1 DNA 
methylation levels. 
Interestingly, the literature indicates that PFAS exposure can alter other markers of global 
DNA methylation and methylation patterns of specific genes without impacting LINE-1 DNA 
methylation (33, 43, 44). One study that analyzed LINE-1 and Alu methylation, another proxy of 
global DNA methylation, found that PFOS exposure was correlated with low Alu methylation 
levels in cord blood DNA but had no effect on LINE-1 DNA methylation (34, 44). Other studies 
that analyzed DNA methylation in offspring peripheral leukocytes found a correlation between 
PFOA and significant methylation changes in multiple elements of specific genes (33, 43). 
Further research is needed to investigate how PFOS, PFOA and GenX exposure affects other 
global markers of DNA methylation and the DNA methylation patterns of specific genes.  
Although PFAS exposure has been shown to alter LINE-1 DNA methylation, the 
prevailing research is inconclusive and varies by chemical. In one study, PFOS exposure is 
correlated with alterations in LINE-1 methylation in peripheral blood leukocytes, while PFOA 
exposure demonstrated no correlation (37). Other studies have found no significant correlation 
between PFOS or PFOA and LINE-1 methylation in cord blood DNA (43, 44). Another study 
found that a significant positive association between PFOA and LINE-1 methylation in sperm in 
one of the populations studied (28). However, when a multivariate linear regression analysis of 
the combined populations was performed, no significant association was found (28). Such mixed 
findings are common in studies investigating the impact of PFAS on the LINE-1 DNA 
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methylation, suggesting that further analysis is needed to fully elucidate the impact of PFAS on 
LINE-1 and global DNA methylation.  
It is also important to consider the differences between in vitro testing methods and the 
human placenta in vivo. The JEG3 cell line is limited in that it is derived from a differentiated 
human tissue and therefore has a more stable epigenome in comparison to tissue that is not fully 
differentiated. Therefore, PFAS exposure may exert a larger effect on placental methylation 
during sensitive developmental processes in utero. Since PFOA has been shown to induce 
developmental toxicity via a mechanism that potentially interferes with placental trophoblast cell 
differentiation, it is important to analyze the impact of PFAS on DNA methylation of placental 
trophoblastic cells undergoing differentiation (13).  
To conclude, this experiment found that PFOS, PFOA and GenX do not alter LINE-1 
DNA methylation regardless of media in the JEG3 placental trophoblastic cell line, which 
provides evidence that these PFAS do not alter global DNA methylation in this cell line. The 
results tentatively imply that PFOS, PFOA and GenX do not alter global DNA methylation in 
placental trophoblasts. Further research is needed to more conclusively determine the effect of 
these PFAS on placental global DNA methylation and on methylation patterns of specific genes, 
especially those identified in previous research (33, 43). Because dysregulation of placental 
DNA methylation has been associated with poor developmental outcomes, it remains important 
to more specifically determine the impact of PFAS on placental DNA methylation and on 
alternative epigenetic mechanisms (30-32).  
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Appendix 
A. PFOS, PFOA and GenX effect on epigenetic machinery protein mRNA expression in serum 
(S+) and serum free (S-) media.  
 
Cells were treated with 10, 100 and 1000 mg/mL of  PFOS, PFOA and GenX in S+ and 
S- media. MTA2 expression was significantly upregulated following treatment with PFOA and 
GenX at 1000 ng/mL. Figure Credit: Jacqueline Bangma and John Szilagyi.  
B. Media composition, manufacturer and purchasing information for components of serum 
media (S+) and serum free media (S-). 




Minimum Essential Media (MEM) 500 mL Gibco 11095-080 
Pen/Strep 100X 5 mL Corning 30-002-CI 
Fetal Bovine Serum (10%) 50 mL EMD Milipore Corp. TMS-013-B 





OptiPRO Serum Free Media (S-) 490 mL Gibco 12309-019 
Pen/Strep 100X 0.5 mL Corning 30-002-CI 
L-glutamine 200X 10 mL ThermoFisher Scientific 25030081 
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Serum free media for this study was a supplemented media (OptiPRO serum free media) 
that is able to sustain cells (not serum starved) without the addition of fetal bovine serum (FBS). 
S- media contained 10% of the Pen/Strep 100X contained in S+ media to account for the absence 
of serum binding, which reduces cellular exposure. (29).  
C: PFOS, PFOA and GenX manufacturer and purchasing information 
Chemical Name Abbreviation Manufacturer CAS 
Perfluorooctane sulfonic acid PFOS Synquest Laboratories 335-67-1 




Trade name: GenX 
Synquest Laboratories 13252-13-6 
PFOS, PFOA and GenX chemical name, abbreviation, manufacturer and purchasing 
information. 
D. Plate Design: Treatment order 








































































































































































 control   control  
Red text represents S- media, black text represents S- media. Treatments were 
randomized across each plate but are depicted in sequential order in this image for clarity. 
Biological replicates of PFOS and PFOA were conducted in triplicate, GenX in quintuplicate. 
Figure credit: Jacqueline Bangma. 
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E. LINE-1 DNA methylation post-hoc analysis of combined serum (S+) and serum free (S-) 
treatment groups. 
Tukey's multiple comparisons test Mean Diff. 95.00% CI of diff. Significant? 
Adjusted P 
Value 
S+ Control vs. S+ PFOS 100 -0.1063 -0.5312 to 0.3186 No 0.9995 
S+ Control vs. S+ PFOS 1000 0.1187 -0.3062 to 0.5436 No 0.9984 
S+ Control vs. S+ PFOA 100 -0.02699 -0.4519 to 0.3979 No >0.9999 
S+ Control vs. S+ PFOA 1000 0.03451 -0.3904 to 0.4594 No >0.9999 
S+ Control vs. S+ GenX 100 0.1656 -0.2593 to 0.5905 No 0.97 
S+ Control vs. S+ GenX 1000 0.2138 -0.2111 to 0.6387 No 0.8391 
S+ Control vs. S- Control 0 -0.4249 to 0.4249 No >0.9999 
S+ Control vs. S- PFOS 100 0.019 -0.4059 to 0.4439 No >0.9999 
S+ Control vs. S- PFOS 1000 0.1284 -0.2965 to 0.5533 No 0.9966 
S+ Control vs. S- PFOA 100 -0.02546 -0.4503 to 0.3994 No >0.9999 
S+ Control vs. S- PFOA 1000 -0.1918 -0.6166 to 0.2331 No 0.9158 
S+ Control vs. S- GenX 100 -0.09738 -0.5223 to 0.3275 No 0.9998 
S+ Control vs. S- GenX 1000 -0.2164 -0.6413 to 0.2085 No 0.8282 
S+ PFOS 100 vs. S+ PFOS 1000 0.225 -0.1998 to 0.6499 No 0.7895 
S+ PFOS 100 vs. S+ PFOA 100 0.07932 -0.3456 to 0.5042 No >0.9999 
S+ PFOS 100 vs. S+ PFOA 1000 0.1408 -0.2841 to 0.5657 No 0.9921 
S+ PFOS 100 vs. S+ GenX 100 0.2719 -0.1530 to 0.6968 No 0.5404 
S+ PFOS 100 vs. S+ GenX 1000 0.3201 -0.1048 to 0.7450 No 0.2999 
S+ PFOS 100 vs. S- Control 0.1063 -0.3186 to 0.5312 No 0.9995 
S+ PFOS 100 vs. S- PFOS 100 0.1253 -0.2996 to 0.5502 No 0.9973 
S+ PFOS 100 vs. S- PFOS 1000 0.2347 -0.1902 to 0.6596 No 0.7424 
S+ PFOS 100 vs. S- PFOA 100 0.08085 -0.3440 to 0.5057 No >0.9999 
S+ PFOS 100 vs. S- PFOA 1000 -0.08545 -0.5103 to 0.3394 No >0.9999 
S+ PFOS 100 vs. S- GenX 100 0.008929 -0.4160 to 0.4338 No >0.9999 
S+ PFOS 100 vs. S- GenX 1000 -0.1101 -0.5350 to 0.3148 No 0.9992 
S+ PFOS 1000 vs. S+ PFOA 100 -0.1457 -0.5706 to 0.2792 No 0.9894 
S+ PFOS 1000 vs. S+ PFOA 1000 -0.08423 -0.5091 to 0.3407 No >0.9999 
S+ PFOS 1000 vs. S+ GenX 100 0.04688 -0.3780 to 0.4718 No >0.9999 
S+ PFOS 1000 vs. S+ GenX 1000 0.09504 -0.3299 to 0.5199 No 0.9998 
S+ PFOS 1000 vs. S- Control -0.1187 -0.5436 to 0.3062 No 0.9984 
S+ PFOS 1000 vs. S- PFOS 100 -0.09974 -0.5246 to 0.3251 No 0.9997 
S+ PFOS 1000 vs. S- PFOS 1000 0.009659 -0.4152 to 0.4345 No >0.9999 
S+ PFOS 1000 vs. S- PFOA 100 -0.1442 -0.5691 to 0.2807 No 0.9903 
S+ PFOS 1000 vs. S- PFOA 1000 -0.3105 -0.7354 to 0.1144 No 0.3421 
S+ PFOS 1000 vs. S- GenX 100 -0.2161 -0.6410 to 0.2088 No 0.8293 
S+ PFOS 1000 vs. S- GenX 1000 -0.3351 -0.7600 to 0.08977 No 0.2408 
S+ PFOA 100 vs. S+ PFOA 1000 0.0615 -0.3634 to 0.4864 No >0.9999 
S+ PFOA 100 vs. S+ GenX 100 0.1926 -0.2323 to 0.6175 No 0.9134 
S+ PFOA 100 vs. S+ GenX 1000 0.2408 -0.1841 to 0.6657 No 0.7112 
S+ PFOA 100 vs. S- Control 0.02699 -0.3979 to 0.4519 No >0.9999 
S+ PFOA 100 vs. S- PFOS 100 0.04598 -0.3789 to 0.4709 No >0.9999 
S+ PFOA 100 vs. S- PFOS 1000 0.1554 -0.2695 to 0.5803 No 0.9819 
S+ PFOA 100 vs. S- PFOA 100 0.00153 -0.4234 to 0.4264 No >0.9999 
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S+ PFOA 100 vs. S- PFOA 1000 -0.1648 -0.5897 to 0.2601 No 0.9712 
S+ PFOA 100 vs. S- GenX 100 -0.0704 -0.4953 to 0.3545 No >0.9999 
S+ PFOA 100 vs. S- GenX 1000 -0.1894 -0.6143 to 0.2355 No 0.9223 
S+ PFOA 1000 vs. S+ GenX 100 0.1311 -0.2938 to 0.5560 No 0.9959 
S+ PFOA 1000 vs. S+ GenX 1000 0.1793 -0.2456 to 0.6042 No 0.9464 
S+ PFOA 1000 vs. S- Control -0.03451 -0.4594 to 0.3904 No >0.9999 
S+ PFOA 1000 vs. S- PFOS 100 -0.01552 -0.4404 to 0.4094 No >0.9999 
S+ PFOA 1000 vs. S- PFOS 1000 0.09389 -0.3310 to 0.5188 No 0.9999 
S+ PFOA 1000 vs. S- PFOA 100 -0.05997 -0.4849 to 0.3649 No >0.9999 
S+ PFOA 1000 vs. S- PFOA 1000 -0.2263 -0.6512 to 0.1986 No 0.7838 
S+ PFOA 1000 vs. S- GenX 100 -0.1319 -0.5568 to 0.2930 No 0.9956 
S+ PFOA 1000 vs. S- GenX 1000 -0.2509 -0.6758 to 0.1740 No 0.6568 
S+ GenX 100 vs. S+ GenX 1000 0.04816 -0.3767 to 0.4731 No >0.9999 
S+ GenX 100 vs. S- Control -0.1656 -0.5905 to 0.2593 No 0.97 
S+ GenX 100 vs. S- PFOS 100 -0.1466 -0.5715 to 0.2783 No 0.9888 
S+ GenX 100 vs. S- PFOS 1000 -0.03722 -0.4621 to 0.3877 No >0.9999 
S+ GenX 100 vs. S- PFOA 100 -0.1911 -0.6160 to 0.2338 No 0.9177 
S+ GenX 100 vs. S- PFOA 1000 -0.3574 -0.7823 to 0.06752 No 0.1695 
S+ GenX 100 vs. S- GenX 100 -0.263 -0.6879 to 0.1619 No 0.5899 
S+ GenX 100 vs. S- GenX 1000 -0.382 -0.8069 to 0.04289 No 0.1112 
S+ GenX 1000 vs. S- Control -0.2138 -0.6387 to 0.2111 No 0.8391 
S+ GenX 1000 vs. S- PFOS 100 -0.1948 -0.6197 to 0.2301 No 0.907 
S+ GenX 1000 vs. S- PFOS 1000 -0.08538 -0.5103 to 0.3395 No >0.9999 
S+ GenX 1000 vs. S- PFOA 100 -0.2392 -0.6641 to 0.1857 No 0.7192 
S+ GenX 1000 vs. S- PFOA 1000 -0.4055 -0.8304 to 0.01936 No 0.0724 
S+ GenX 1000 vs. S- GenX 100 -0.3112 -0.7360 to 0.1137 No 0.3391 
S+ GenX 1000 vs. S- GenX 1000 -0.4302 -0.8551 to -0.005269 Yes 0.0451 
S- Control vs. S- PFOS 100 0.019 -0.4059 to 0.4439 No >0.9999 
S- Control vs. S- PFOS 1000 0.1284 -0.2965 to 0.5533 No 0.9966 
S- Control vs. S- PFOA 100 -0.02546 -0.4503 to 0.3994 No >0.9999 
S- Control vs. S- PFOA 1000 -0.1918 -0.6166 to 0.2331 No 0.9158 
S- Control vs. S- GenX 100 -0.09738 -0.5223 to 0.3275 No 0.9998 
S- Control vs. S- GenX 1000 -0.2164 -0.6413 to 0.2085 No 0.8282 
S- PFOS 100 vs. S- PFOS 1000 0.1094 -0.3155 to 0.5343 No 0.9993 
S- PFOS 100 vs. S- PFOA 100 -0.04445 -0.4693 to 0.3804 No >0.9999 
S- PFOS 100 vs. S- PFOA 1000 -0.2108 -0.6356 to 0.2141 No 0.8513 
S- PFOS 100 vs. S- GenX 100 -0.1164 -0.5413 to 0.3085 No 0.9987 
S- PFOS 100 vs. S- GenX 1000 -0.2354 -0.6603 to 0.1895 No 0.739 
S- PFOS 1000 vs. S- PFOA 100 -0.1539 -0.5787 to 0.2710 No 0.9833 
S- PFOS 1000 vs. S- PFOA 1000 -0.3202 -0.7450 to 0.1047 No 0.2996 
S- PFOS 1000 vs. S- GenX 100 -0.2258 -0.6507 to 0.1991 No 0.7861 
S- PFOS 1000 vs. S- GenX 1000 -0.3448 -0.7697 to 0.08011 No 0.2075 
S- PFOA 100 vs. S- PFOA 1000 -0.1663 -0.5912 to 0.2586 No 0.9691 
S- PFOA 100 vs. S- GenX 100 -0.07193 -0.4968 to 0.3530 No >0.9999 
S- PFOA 100 vs. S- GenX 1000 -0.1909 -0.6158 to 0.2340 No 0.9181 
S- PFOA 1000 vs. S- GenX 100 0.09438 -0.3305 to 0.5193 No 0.9999 
S- PFOA 1000 vs. S- GenX 1000 -0.02463 -0.4495 to 0.4003 No >0.9999 
S- GenX 100 vs. S- GenX 1000 -0.119 -0.5439 to 0.3059 No 0.9984 
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Post-hoc Tukey’s multiple comparison test with a single pooled variance was conducted 
to test for differences between corresponding treatment groups in S+ and S- media. Significant 
differences are highlighted in yellow. The ANOVA conducted prior to this post-hoc analysis 
analyzed all data from S+ and S- media in order to increase statistical precision by improving the 
estimate of variance. Specifically, this served to decrease the effect of outliers on variance and 
therefore to reduce the likelihood of a false positive. Significance was set at p < 0.05. Treatment 
groups were able to be compared between media type (S+ and S-) because each treatment group 
was previously standardized to its respective control in either S+ or S- media.  
F. PFAS effect on global LINE-1 DNA methylation in serum media (S+) and serum free media 
(S-). 
 
Data are means. Error bars are confidence intervals. Treatment concentration is ng/mL. 
Solid horizonal black lines indicate the average value of the control, dashed lines indicate the 
confidence interval of the control for S+ media and S- media, respectively. Compounds tested 
were PFOS, PFOA and GenX at 100 and 1000 ng/mL. LINE-1 DNA Methylation values are 
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standardized to respective controls. No significant changes in LINE-1 DNA methylation from 
the control were observed in ANOVA analysis (p < 0.05). 
 
